Matt Sassone, CEO, discusses how the company is delivering on its strategy, seeing strong growth in US and positive feedback from independent clinical trials.
Matt Sassone, CEO, discusses how the company is delivering on its strategy, seeing strong growth in US and positive feedback from independent clinical trials.